,src,lang,text
0,"











新一代基因編輯誕生 可修復九成遺傳病？

04 Nov 2019, 02:34

【新唐人北京時間2019年11月04日訊】近期發表在《自然》（Nature）雜誌上的一篇研究稱發明了一種名為「最佳編輯」（prime editor）的基因編輯技術，比2012年誕生的CRISPR更準確，而且編輯範圍更廣。研究者稱可以「修復89%已知的人類遺傳病」。
CRISPR基因編輯有不少局限性，有的時候會改變目標之外的基因導致意外的後果。新研究的主要作者之一、美國哈佛-麻省理工的博德研究所（Broad Institute of MIT and Harvard）的化學家劉如謙（David Liu）說：「如果Crispr-Cas9像一把剪刀，基礎編輯器（base editors）像鉛筆，那prime editors就像文字處理器。」
根據劉如謙的計算，這種新的基因編輯技術可以解決人類89%已知的遺傳疾病。他們公布的研究在人類細胞培養皿中編輯了175種遺傳疾病基因，其中包括貧血、囊性纖維化和家族黑蒙性癡呆症（Tay-sachs）。
傳統CRISPR基因編輯方法由兩個部分構成：用於切割DNA的生化酶Cas9，和把生化酶引導至目標切割地點的RNA。其它的酶可完成不同的任務，如附著在一個基因上將其關閉，或打開DNA置換裡面的字母。
新方法使用的酶是一種起著切割刀作用的分子與另一種把RNA變成DNA的逆轉錄酶的結合體。新方法使用的RNA也不同，不僅負責找到目標編輯地，還攜帶一份用於編輯的版本。當它找到目標DNA，在表面做個小記號，接著轉錄酶把正確的DNA序列逐個字母地加入RNA帶來的版本，就像「打字機逐個地敲出字母」一樣。結果得到兩份DNA，一份原始的（被做過標記的），一份編輯後的。最後啟動細胞的修復機制，把原始的片段切除，讓編輯後的版本「永久地留在那裡」。
沒有參與這份研究的同行、澳大利亞國立大學（ANU）的基因學家布爾吉歐（GaétanBurgio）表示，這份研究「對細胞編輯有巨大的潛力，可能是革命性的」。
布爾吉歐也提到，這種新方法面臨的一個大問題是，相對於細胞層面，這種「編輯器」太大，無法裝入病毒內，研究者通常用病毒將編輯元件送進細胞中。這樣大的體積還可能會堵塞用於微注射的針頭，這使得向老鼠、或人體胚胎注射非常困難。
──轉自《大紀元》
（責任編輯：葉萍）
本文網址: https://www.ntdtv.com/b5/2019/11/03/a102699303.html


",zh-TW,"











The birth of a new generation of genetic editing can repair 90% of genetic diseases?

04 Nov 2019, 02:34

[New Tang Dynasty, Beijing time, November 04, 2019] A recent study published in the journal Nature reported that a gene editing technique called ""prime editor"" was invented, compared to 2012. The birth of CRISPR is more accurate and has a wider range of editing. Researchers say they can ""repair 89% of known human genetic diseases.""
CRISPR gene editing has a number of limitations, sometimes changing the genes outside the target to cause unexpected consequences. David Liu, a chemist at the Broad Institute of MIT and Harvard, one of the lead authors of the new study, said: ""If Crispr-Cas9 is like a pair of scissors, the basic editor (base editors) Like pencils, prime editors are like word processors.""
According to Liu Ruqian's calculations, this new gene editing technology can solve 89% of the known genetic diseases in humans. Their published study edited 175 genetic disease genes in human cell culture dishes, including anemia, cystic fibrosis, and family Tay-sachs.
The traditional CRISPR gene editing method consists of two parts: the biochemical enzyme Cas9 for cutting DNA, and the RNA that directs the biochemical enzyme to the target cleavage site. Other enzymes can perform different tasks, such as attaching to a gene to turn it off, or opening a letter in a DNA replacement.
The enzyme used in the new method is a combination of a molecule that acts as a cutting knife and another reverse transcriptase that turns RNA into DNA. The new method uses a different RNA, not only responsible for finding the target editing location, but also carrying a version for editing. When it finds the target DNA, it makes a small mark on the surface, and then the transcriptase adds the correct DNA sequence to the version brought by the RNA one by one, just like ""the typewriter knocks out the letters one by one."" The result is two copies of DNA, one original (marked), and one edited. Finally, the cell repair mechanism is initiated, the original fragment is excised, and the edited version is ""permanently left there.""
Gaétan Burgio, a geneticist at the Australian National University (ANU), who did not participate in the study, said the study ""has great potential for cell editing and may be revolutionary.""
Bourgeois also mentioned that one of the big problems with this new approach is that the ""editor"" is too large to fit into the virus at the cellular level, and researchers often use viruses to send editing components into cells. . Such large volumes may also block needles for microinjection, which makes it very difficult to inject into mice, or human embryos.
─Transfer from the Epoch Times
(Editor: Ye Ping)
This article URL: https://www.ntdtv.com/b5/2019/11/03/a102699303.html


"
